FDA cuts off use of GSK's Covid treatment in almost half of the US as BA.2 spreads
With the rise of the Omicron sister variant BA.2, GlaxoSmithKline and Vir Biotechnology’s crucial monoclonal antibody — one of only two mAbs still being shipped by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
